These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25475427)

  • 1. The role of 5α-reductase type 1 associated with intratumoral dihydrotestosterone concentrations in human endometrial carcinoma.
    Tanaka S; Miki Y; Hashimoto C; Takagi K; Doe Z; Li B; Yaegashi N; Suzuki T; Ito K
    Mol Cell Endocrinol; 2015 Feb; 401():56-64. PubMed ID: 25475427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders.
    Ito K; Suzuki T; Akahira J; Moriya T; Kaneko C; Utsunomiya H; Yaegashi N; Okamura K; Sasano H
    Int J Cancer; 2002 Jun; 99(5):652-7. PubMed ID: 12115497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer.
    Hashimoto C; Miki Y; Tanaka S; Takagi K; Fue M; Doe Z; Li B; Yaegashi N; Suzuki T; Ito K
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production.
    Suzuki T; Miki Y; Moriya T; Akahira J; Ishida T; Hirakawa H; Yamaguchi Y; Hayashi S; Sasano H
    Int J Cancer; 2007 Jan; 120(2):285-91. PubMed ID: 17066438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions.
    Suzuki T; Darnel AD; Akahira JI; Ariga N; Ogawa S; Kaneko C; Takeyama J; Moriya T; Sasano H
    J Clin Endocrinol Metab; 2001 May; 86(5):2250-7. PubMed ID: 11344235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5α-reduction of epitestosterone is catalysed by human SRD5A1 and SRD5A2 and increases androgen receptor transactivation.
    Schiffer L; Arlt W; Storbeck KH
    J Steroid Biochem Mol Biol; 2024 Jul; 241():106516. PubMed ID: 38582131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3.
    Negri-Cesi P; Colciago A; Poletti A; Motta M
    Prostate; 1999 Dec; 41(4):224-32. PubMed ID: 10544295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of lysophosphatidic acid receptors, in association with the synthesis of estrogens and androgens in type 1 endometrial cancer biology.
    Wasniewski T; Woclawek-Potocka I
    Gynecol Endocrinol; 2018 May; 34(5):422-427. PubMed ID: 29182028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen inactivation in human lung fibroblasts: variations in levels of 17 beta-hydroxysteroid dehydrogenase type 2 and 5 alpha-reductase activity compatible with androgen inactivation.
    Provost PR; Blomquist CH; Drolet R; Flamand N; Tremblay Y
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3883-92. PubMed ID: 12161528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer.
    Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D
    Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen physiology: unsolved problems at the millennium.
    Wilson JD; Leihy MW; Shaw G; Renfree MB
    Mol Cell Endocrinol; 2002 Dec; 198(1-2):1-5. PubMed ID: 12573808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ androgen and estrogen biosynthesis in endometrial cancer: focus on androgen actions and intratumoral production.
    Ito K; Miki Y; Suzuki T; McNamara KM; Sasano H
    Endocr Relat Cancer; 2016 Jul; 23(7):R323-35. PubMed ID: 27287451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
    Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
    J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators.
    An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ
    Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
    Issa S; Schnabel D; Feix M; Wolf L; Schaefer HE; Russell DW; Schweikert HU
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5401-7. PubMed ID: 12466325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the alternate pathway of dihydrotestosterone formation in virilization of the Wolffian ducts of the tammar wallaby, Macropus eugenii.
    Shaw G; Fenelon J; Sichlau M; Auchus RJ; Wilson JD; Renfree MB
    Endocrinology; 2006 May; 147(5):2368-73. PubMed ID: 16469812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen formation and metabolism in the pulmonary epithelial cell line A549: expression of 17beta-hydroxysteroid dehydrogenase type 5 and 3alpha-hydroxysteroid dehydrogenase type 3.
    Provost PR; Blomquist CH; Godin C; Huang XF; Flamand N; Luu-The V; Nadeau D; Tremblay Y
    Endocrinology; 2000 Aug; 141(8):2786-94. PubMed ID: 10919264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgens in endometrial carcinoma: the killer or helper?
    Wu X; Zhang K; Zhong X; Huo X; Zhang J; Tian W; Yang X; Zhang Y; Wang Y
    J Endocrinol Invest; 2023 Mar; 46(3):457-464. PubMed ID: 36583833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability.
    Boehmer AL; Brinkmann AO; Nijman RM; Verleun-Mooijman MC; de Ruiter P; Niermeijer MF; Drop SL
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1240-6. PubMed ID: 11238515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between the expression of dual specificity phosphatase-1 and the prognosis of endometrioid adenocarcinoma].
    Gao BR; Yao YY; Chen YH; Li XP; Wang JL; Wei LH
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2493-5. PubMed ID: 24300273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.